Novartis South Africa
Novartis South Africa is the Johannesburg-based South African subsidiary of Swiss pharmaceutical company Novartis AG, developing and distributing prescription medicines across cardiovascular, immunology, neuroscience, and oncology therapeutic areas to both private and public healthcare sectors.
- Company typePublic
- Founded1996
- Headquarters—
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
Novartis South Africa firmographics
Firmographics- Name
- Novartis South Africa
- Legal name
- Novartis AG
- Website
- https://novartis.co.za
- Company type
- Public
- Founded year
- 1996
- Operating status
- Operating
- Short description
- Novartis South Africa is the Johannesburg-based South African subsidiary of Swiss pharmaceutical company Novartis AG, developing and distributing prescription medicines across cardiovascular, immunology, neuroscience, and oncology therapeutic areas to both private and public healthcare sectors.
- Ownership category
- akta.pro rank
Novartis South Africa industry classification
Industry- Product category
- Prescription Pharmaceuticals
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Neurology & Psychiatry (CNS) Pharmaceuticals (HLAIAAAF)
- akta.pro secondary industry
- Specialty Pharmacy & Biologics Distribution (CRAOAHAD)
Keywords
Novartis South Africa business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Revenue model
- Pharmaceutical medicines sales: Novartis South Africa generates revenue through the sale of prescription medicines to healthcare providers, hospitals, pharmacies, and patients in both private and public healthcare sectors across South Africa.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Novartis South Africa product offering
Product offeringCore offering
Novartis South Africa is a pharmaceutical subsidiary that develops, manufactures, and distributes innovative prescription medicines across four core therapeutic areas: cardiovascular, renal and metabolic; immunology; neuroscience; and oncology. The company serves patients through healthcare professionals, hospitals, and pharmacies in both private and public healthcare sectors across South Africa.
Product overview
Novartis South Africa is a pharmaceutical company subsidiary operating within the global Novartis network. The company focuses on innovative medicines across four main therapeutic areas: Cardiovascular, Renal and Metabolic; Immunology; Neuroscience; and Oncology. The company operates as a traditional pharmaceutical manufacturer and distributor, providing prescription medicines to healthcare professionals and patients in both private and public healthcare sectors. The product portfolio includes treatments for specific disease conditions such as atherosclerotic cardiovascular disease, chronic myeloid leukemia, multiple sclerosis, breast cancer, hidradenitis suppurativa, and juvenile idiopathic arthritis. As a pharmaceutical subsidiary, the company does not operate a software platform or technology product offering in the traditional SaaS sense.
Differentiator
Problem solved
Functional benefit
Products and services
- Cardiovascular, Renal and Metabolic Portfolio Novartis therapeutic portfolio focused on treatments for cardiovascular diseases, renal conditions, and metabolic disorders including atherosclerotic cardiovascular disease and related conditions. Distributed to healthcare professionals, hospitals, and pharmacies in South Africa.
- Immunology Portfolio Novartis therapeutic portfolio focused on immunology treatments including autoimmune and inflammatory conditions such as hidradenitis suppurativa and juvenile idiopathic arthritis. Distributed to healthcare professionals and institutions in South Africa.
- Neuroscience Portfolio Novartis therapeutic portfolio focused on neurological and neuroscience treatments including multiple sclerosis and other central nervous system disorders. Distributed to healthcare professionals and institutions in South Africa.
- Oncology Portfolio Novartis therapeutic portfolio focused on cancer treatments including breast cancer, chronic myeloid leukemia, and other oncological conditions. Distributed to healthcare professionals and institutions in South Africa.
Companies that use Novartis South Africa
Customer profileSegments4 records
Ideal customer profiles3 records
Novartis South Africa technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Novartis South Africa partnerships and signals
Strategic signalScale indicators2 records
Recent moves4 records
Expansion highlights4 records
Novartis South Africa competitors and assessment
Company assessmentDirect peers
- Pfizer South Africa: Pfizer South Africa is a wholly-owned multinational pharma affiliate operating in the same South African market with a similar multi-therapeutic-area branded pharmaceutical portfolio (including oncology, vaccines, internal medicine, and inflammation/immunology). Direct comparability in business model, distribution channels, and regulatory exposure is near-identical to Novartis South Africa.
- Roche South Africa: Roche South Africa is a Swiss-headquartered multinational pharma affiliate with overlapping branded oncology, immunology, and neuroscience portfolios targeting the same South African prescribers, hospitals, and pharmacies through analogous field-sales distribution channels. Comparable across all major dimensions including parent-country, therapeutic mix, and channel structure.
- Johnson & Johnson Innovative Medicine South Africa: Johnson & Johnson's South African pharma subsidiary operates a comparable branded innovator portfolio across oncology, immunology, and neuroscience — overlapping directly with Novartis South Africa in oncology, hematology, and immunology therapeutic areas. Same market, same channel structure, same regulatory regime.
- MSD (Merck) South Africa: MSD South Africa is a US-headquartered multinational pharma affiliate offering branded innovator therapies in oncology, vaccines, and primary-care specialties with near-identical distribution through HCPs, hospitals, and pharmacies. Direct overlap with Novartis South Africa in oncology and immunology.
- Sanofi South Africa: Sanofi South Africa is a French-headquartered multinational pharma subsidiary with overlapping branded portfolios in immunology (Dupixent-equivalent TAs), vaccines, and cardiometabolic diseases. Distribution model and regulatory environment are identical to Novartis South Africa.
- AstraZeneca South Africa: AstraZeneca South Africa is a UK-headquartered pharma affiliate whose branded portfolio overlaps directly with Novartis South Africa in oncology (breast/lung cancer) and cardiovascular/renal/metabolic disease. Same enterprise field-sales GTM, same hospital/clinic/channel structure.
- GSK South Africa: GSK operates a South African pharma subsidiary with overlapping branded portfolios across specialty medicines, vaccines, and HIV — serving the same HCP/hospital/pharmacy channel structure. Direct competitor in immunology and respiratory adjacencies.
- Bayer South Africa: Bayer South Africa is a German-headquartered multinational pharma affiliate with overlapping cardiology and women's health product lines served through the same HCP and pharmacy distribution channels as Novartis South Africa. Comparable scale, structure, and regulatory exposure.
- Abbott Laboratories South Africa: Abbott's South African pharmaceutical operations target the same hospital, HCP, and pharmacy channels with branded products spanning cardiovascular, immunology, and infectious disease — directly comparable in portfolio breadth and distribution to Novartis South Africa.
- Bristol-Myers Squibb South Africa: Bristol-Myers Squibb operates a South African affiliate focused on branded oncology and immunology products — directly overlapping with Novartis South Africa's CML and breast cancer franchises and distributed through the same hospital and specialty channel structure.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights5 records
Customer concentration
Novartis South Africa social profiles
Digital presenceNovartis South Africa compliance and trust
Trust signalCompliance1 record
Novartis South Africa financial estimates
Financial estimateRevenue estimate
Valuation estimate
Novartis South Africa leadership team
Management profileNumber of profiles
Novartis South Africa funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Novartis South Africa M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Novartis South Africa
What does Novartis South Africa do?
Novartis South Africa is a pharmaceutical subsidiary that develops, manufactures, and distributes innovative prescription medicines across four core therapeutic areas: cardiovascular, renal and metabolic; immunology; neuroscience; and oncology. The company serves patients through healthcare professionals, hospitals, and pharmacies in both private and public healthcare sectors across South Africa.
Is Novartis South Africa a public or private company?
Novartis South Africa is a public company. It is classified as corporate owned and is currently operating.
When was Novartis South Africa founded?
Novartis South Africa was founded in 1996.
How does Novartis South Africa make money?
One revenue line is on record: pharmaceutical medicines sales.
Who are Novartis South Africa's main competitors?
Direct peers on record are Pfizer South Africa, Roche South Africa, Johnson & Johnson Innovative Medicine South Africa, MSD (Merck) South Africa, Sanofi South Africa, AstraZeneca South Africa, GSK South Africa, Bayer South Africa, Abbott Laboratories South Africa and Bristol-Myers Squibb South Africa.
Does Novartis South Africa have an API?
No public API is recorded for Novartis South Africa.
What industry is Novartis South Africa in?
Novartis South Africa's product category is Prescription Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAF, Neurology & Psychiatry (CNS) Pharmaceuticals, with a secondary code of CRAOAHAD, Specialty Pharmacy & Biologics Distribution. Its NAICS code is 3254 and its SIC code is 2834.